Huah Shin is currently a Post-Doctoral Research Fellow at the University of British Columbia under the supervision of Prof. Helen Tremlett. She completed her Bachelor of Pharmacy (Hons) and a PhD in Pharmacy, both from the University of South Australia, Australia. She is also a pharmacist with experiences working in both hospital and community settings. Her research interests include pharmacoepidemiology, medication safety and effectiveness, and chronic diseases.
Huah Shin’s current post-doctoral research at UBC (January 2019-present) focuses on the assessment of the real-world safety profiles and effectiveness of disease-modifying drugs in the multiple sclerosis population. She will conduct a series of observational studies using linked administrative health data in British Columbia to investigate both long-term benefits and potential adverse effects for a wide spectrum of disease-modifying drugs for multiple sclerosis. In addition to a MSFHR Trainee Award, Huah Shin also receives funding from the Multiple Sclerosis Society of Canada’s endMS Post-Doctoral Fellowship and the Canadian Institutes of Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program (DSECT) Award in 2019.
For an up-to-date list of publications by Dr. Shin, please see Google Scholar.